Aim The use of proton pump inhibitor (PPI) treatments are increasing among paediatric
patients worldwide. We aimed to review the effects of PPIs on the microbiome and its …

Proton pump inhibitors (PPIs) are the standard therapy for gastroesophageal reflux disease.
In adults, PPI treatment is associated with Clostridium difficile infections (CDI). In contrast to …

Abstract Purpose of Review The evidence supporting or contesting the prescription of proton
pump inhibitors (PPIs) for children and updates on side effects are reviewed. Recent …

Proton pump inhibitors (PPIs) are amongst the most commonly prescribed drugs in infants
and children with the last decades witnessing a dramatic rise in their utilization. Although …

Objective Proton pump inhibitors (PPIs) are drugs used to suppress gastric acid production
and treat GI disorders such as peptic ulcers and gastro-oesophageal reflux. They have been …

Christopher M. Stark, MD, and Cade M. Nylund, MD Proton pump inhibitors (PPIs) are a
class of acid suppression medications that block gastric parietal cell acid production by …

Proton pump inhibitors (PPIs) are common medications within the practice of
gastroenterology. These drugs, which act through the irreversible inhibition of the …

Background Proton pump inhibitors (PPI) are widely used to treat acid‐related disorders of
the upper gastrointestinal tract. However, large observational studies have raised concerns …

Proton pump inhibitors (PPIs) are among the most prescribed drugs worldwide and include
omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole. Their use in …

Importance Proton pump inhibitor (PPI) use may lead to infections through alteration of the
microbiota or direct action on the immune system. However, only a few studies were …